Summary
L-phenylisopropyladenosine (L-PIA; a preferential A1 adenosine agonist—0.05 mg/kg) offered no protection against electroconvulsions in mice but potentiated the anticonvulsant action of diazepam and valproate against maximal electroshock-induced seizures, decreasing the respective ED50 values from 9.5 to 4.0 mg/kg and from 250 to 185 mg/kg. However, it remained without effect on the protective activity of phenobarbital, carbamazepine and diphenylhydantoin. 5′-N-ethylcarboxamidoadenosine (NECA; a preferential A2 adenosine agonist—0.5 mg/kg) potentiated the efficacy of valproate. On the other hand, NECA (1 mg/kg) diminished the anticonvulsant action of phenobarbital (ED50 was elevated from 16.5 to 20.5 mg/kg), possessing no effect upon the protective action of carbamazepine. In addition, papaverine (20 mg/kg) significantly enhanced the protective efficacy of valproate and up to 40 mg/kg remained without influence upon the protective action of carbamazepine. However, papaverine (20 and 40 mg/kg) inhibited the anticonvulsive potential of phenobarbital.
In the light of the results obtained A 1 and A 2 adenosine receptor-mediated events seem to possess different influences upon the protective effects of antiepileptic drugs.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ault B, Olney MA, Joyner LJ, Boyer CE, Notrica MA, Soroko FE, Wang CM (1987) Proconvulsant actions of theophylline and caffeine in the hippocampus: implications for the management of temporal lobe epilepsy. Brain Res 426: 93–102
Ault B, Wang CM (1986) Adenosine inhibits epileptiform activity arising in hippocampal area. Br J Pharmacol 87: 695–703
Bender AS, Wu PH, Phillis JW (1980) The characterization of (3 H)-adenosine uptake into rat cerebral cortical synaptosomes. J Neurochem 33: 629–640
Bortolotto ZA, Mello LE, Turski L, Cavalheiro EA (1985) Effects of 2-chloroadenosine on amygdaloid and hippocampal kindled seizures. Arch Int Pharmacodyn 277: 313–340
Bowker HM, Chapman AG (1986) Adenosine analogues. The temperature dependence of the anticonvulsant effect and inhibition of 3 H-D-aspartate release. Biochem Pharmacol 35: 2949–2953
Bruns RF, Katims JJ, Annau Z, Snyder SH, Daly JW (1983) Adenosine receptor interactions and anxiolytics. Neuropharmacology 22: 1523–1529
Chu N-S (1981) Caffeine- and aminophylline-induced seizures. Epilepsia 22: 85–94
Czuczwar SJ, Ikonomidou C, Kleinrok Z, Turski L, Turski W (1986) Effect of aminophylline on the protective action of common antiepileptic drugs against electroconvulsions in mice. Epilepsia 27: 204–208
Czuczwar SJ, JÄckel R, Löscher W (1987 a) Effects of aminophylline and enprofylline on the protective action of phenobarbital against kindled seizures in rats. Epilepsy Res 1: 234–238
Czuczwar SJ, Janusz W, Wamil A, Kleinrok Z (1987b) Inhibition of aminophylline-induced convulsions in mice by antiepileptic drugs and other agents. Eur J Pharmacol 144: 309–315
Czuczwar SJ, Kleinrok Z, Turski L, Turski WA (1987c) Effect of aminophylline and enprofylline upon the protective efficacy of common antiepileptic drugs against electroconvulsions in mice. Epilepsia 28: 383–386
Czuczwar SJ, Turski L, Ikonomidou C, Turski WA, Kleinrok Z (1987d) Purinergic component in the action of common antiepileptic drugs? In: Wolf P, Dam M, Janz M, Dreifuss FE (eds) Advances in epileptology. Raven Press, New York, pp 511–513
Czuczwar SJ, Turski WA, Ikonomidou C, Turski L (1985) Aminophylline and CGS 8216 reverse the protective action of diazepam against electroconvulsions in mice. Epilepsia 26: 693–696
Dragunov M, Goddard GV, Laverty R (1985) Is adenosine an endogenous anticonvulsant? Epilepsia 26: 480–487
Dunwiddie TV, Worth T (1982) Sedative and anticonvulsant effects of adenosine analogs in mouse and rat. J Pharmacol Exp Ther 220: 70–76
Fujiwara Y, Sato M, Otsuki S (1986) Interaction of carbamazepine and other drugs with adenosine (A 1 and A 2) receptors. Psychopharmacology 90: 332–335
Lee KS, Schubert P, Heinemann U (1984) The anticonvulsant action of adenosine: a postsynaptic, dendritic action by a possible endogenous anticonvulsant. Brain Res 321: 160–164
Litchfield JT, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96: 99–113
Lohse MJ, Klotz K-N, Jakobs KH, Schwabe U (1985) Barbiturates are selective antagonists at A 1 adenosine receptors. J Neurochem 45: 1761–1770
Maitre M, Ciesielski L, Lehmann A, Kempf E, Mandel P (1974) Protective effects of adenosine and nicotinamide against audiogenic seizure. Biochem Pharmacol 23: 2807–2816
Marangos PJ, Weiss SRB, Montgomery P, Patel J, Narang PK, Cappabianca AM, Post RM (1985) Chronic carbamazepine treatment increases brain adenosine receptors. Epilepsia 26: 493–498
Murray TF, Sylvester D, Schultz CS, Szot P (1985) Purinergic modulation of the seizure threshold for pentylenetetrazol in the rat. Neuropharmacology 24: 761–766
O'Shaughnessy CT, Aram JA, Lodge D (1988) A 1 adenosine receptor-mediated block of epileptiform activity induced in zero magnesium in rat neocortex in vitro. Epilepsy Res 2: 294–301
Phillis JW (1984) Interactions of the anticonvulsant diphenylhydantoin and carbamazepine with adenosine on cerebral cortical neurons. Epilepsia 25: 765–772
Phillis JW, Wu PH (1982) The effect of various centrally active drugs on adenosine uptake by the central nervous system. Comp Biochem Physiol 72 C: 179–187
Ribeiro JA, Sebastiao AM (1986) Adenosine receptors and calcium: basis for proposing a third (A 3) adenosine receptor. Prog Neurobiol 26: 179–209
Skerrit JH, Davies LP, Johnston GAR (1982) A purinergic component in the anticonvulsant action of carbamazepine. Eur J Pharmacol 82: 195–197
Skerrit JH, Davies LP, Johnston GAR (1983a) Interactions of the anticonvulsant carbamazepine with adenosine receptors. 1. Neurochemical studies. Epilepsia 24: 634–642
Skerrit JH, Johnston GAR, Chen Chow S (1983b) Interactions of the anticonvulsant carbamazepine with adenosine receptors. 2. Pharmacological studies. Epilepsia 24: 643–650
Swinyard EA, Brown WC, Goodman LS (1952) Comparative assays of antiepileptic drugs in mice and rats. J Pharmacol Exp Ther 106: 319–330
Turski WA, Cavalheiro EA, Ikonomidou C, Moraes Mello LEA, Bortolotto ZA, Turski L (1985) Effects of aminophylline and 2-chloroadenosine on seizures produced by pilocarpine in rats: morphological and electroencephalographic correlates. Brain Res 361: 309–323
Weir RL, Padgett W, Daly JW, Anderson SM (1984) Interaction of anticonvulsant drugs with adenosine receptors in the central nervous system. Epilepsia 25: 492–498
Weiss SRB, Post RM, Marangos PJ, Patel J (1985) Adenosine antagonists—lack of effect on the inhibition of kindled seizures in rats by carbamazepine. Neuropharmacology 24: 635–638
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Czuczwar, S.J., Szczepanik, B., Wamil, A. et al. Differential effects of agents enhancing purinergic transmission upon the antielectroshock efficacy of carbamazepine, diphenylhydantoin, diazepam, phenobarbital, and valproate in mice. J. Neural Transmission 81, 153–166 (1990). https://doi.org/10.1007/BF01245835
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01245835